Lonza Group AG (LZAGY)

Currency in USD
69.02
-0.26(-0.38%)
Closed·
LZAGY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
68.5869.53
52 wk Range
58.5373.85
Key Statistics
Prev. Close
69.28
Open
69.48
Day's Range
68.58-69.53
52 wk Range
58.53-73.85
Volume
43.13K
Average Volume (3m)
62.06K
1-Year Change
-0.0724%
Book Value / Share
143.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LZAGY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
82.14
Upside
+19.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Lonza Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 82.14
(+19.00% Upside)

Earnings

Latest Release
Jul 22, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.47%
Dividend Yield
0.57%
Industry Median 0.86%
Annualized payout
0.40
Paid unevenly
5-Years Growth
+10.76%
Growth Streak

LZAGY Income Statement

Compare LZAGY to Peers and Sector

Metrics to compare
LZAGY
Peers
Sector
Relationship
P/E Ratio
36.4x37.7x−0.4x
PEG Ratio
−0.31−1.410.00
Price/Book
4.8x4.0x2.6x
Price / LTM Sales
5.7x4.3x3.0x
Upside (Analyst Target)
15.0%7.5%51.9%
Fair Value Upside
Unlock2.5%7.2%Unlock

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
27.44M39.29%1.90B
Other Institutional Investors
1.54M2.20%106.52M
Public Companies & Retail Investors
40.87M58.51%2.83B
Total
69.84M100.00%4.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.96%6,957,700482,036
UBS Asset Management AG6.32%4,411,959305,665

People Also Watch

65.270
AXTI
-4.95%
144.56
ENTG
+15.46%
31.13
ATLO
+0.68%
47.73
HUBG
+3.29%
52.02
GFS
+4.02%

FAQ

What Is the Lonza Group AG (LZAGY) Stock Price Today?

The Lonza Group AG stock price today is 69.02 USD.

What Stock Exchange Does Lonza Group AG Trade On?

Lonza Group AG is listed and trades on the OTC Markets.

What Is the Stock Symbol for Lonza Group AG?

The stock symbol for Lonza Group AG is "LZAGY."

Does Lonza Group AG Pay Dividends? What’s The Current Dividend Yield?

The Lonza Group AG dividend yield is 0.57%.

What Is the Lonza Group AG Market Cap?

As of today, Lonza Group AG market cap is 48.02B USD.

What Is Lonza Group AG's Earnings Per Share (TTM)?

The Lonza Group AG EPS (TTM) is 15.47.

When Is the Next Lonza Group AG Earnings Date?

Lonza Group AG will release its next earnings report on Oct 20, 2026.

From a Technical Analysis Perspective, Is LZAGY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Lonza Group AG Stock Split?

Lonza Group AG has split 0 times.

How Many Employees Does Lonza Group AG Have?

Lonza Group AG has 20141 employees.

What is the current trading status of Lonza Group AG (LZAGY)?

As of Aug 05, 2026, Lonza Group AG (LZAGY) is trading at a price of 69.02 USD, with a previous close of 69.28 USD. The stock has fluctuated within a day range of 68.58 USD to 69.53 USD, while its 52-week range spans from 58.53 USD to 73.85 USD.

What Is Lonza Group AG (LZAGY) Price Target According to Analysts?

The average 12-month price target for Lonza Group AG is 82.14 USD, with a high estimate of 87.69183321 USD and a low estimate of 79.07352578 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +19.00% Upside potential.

What Is the LZAGY Premarket Price?

LZAGY's last pre-market stock price is 69.67 USD. The pre-market share volume is 250.00, and the stock has decreased by 0.39, or 0.56%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.